Table 1.
Site | S. No. | Virus | Viral Protein | Host target | Effect on host cell Ca2+ signaling | Relevance to viral pathogenesis | Reference |
---|---|---|---|---|---|---|---|
PM | 1 | IAV | Hemagglutinin (HA) | VGCC | Induces intracellular Ca2+ oscillation | Helps in viral entry and replication | Fujioka et al. (2018) |
2 | HIV-1 | Tat | VGCC | Elevation of intracellular Ca2+ | Host immune dysfunction | Zocchi et al. (1998) | |
3 | Flavivirus (JEV, ZIKV, DENV, YFV and WNV) | NS4B | VGCC | Increases cytosolic Ca2+ | Viral replication | Wang et al. (2017) | |
4 | NWA | Viral glycoproteins(GP) | VGCC | Increases cytosolic Ca2+ | Helps in viral entry and infection | (Lavanya et al., 2013; Sarute and Ross, 2020) | |
5 | HBV | HBx | Orai1 | Increases cytosolic Ca2+ | Essential for HBV replication | (Yao et al., 2018) | |
6 | HTLV-1 | p12I | SOCC | Elevation of cytoplasmic Ca2+ | Aids in viral replication | Ding et al. (2002) | |
7 | RV | NSP4 | SOCC | SOCE activation, increases cytoplasmic Ca2+ levels | Aid in viral replication | (Díaz et al., 2012; Hyser et al., 2013) | |
8 | DENV | Not known | Orai1 | Rise in cytosolic Ca2+ | Viral replication | Dionicio et al. (2018) | |
9 | Arenavirus and Filovirus | VP40 | Orai1 | Rise in cytosolic Ca2+ levels | Viral budding and spread | Han et al. (2015) | |
10 | HIV-1 | Gp120, Tat | NMDAR | Increases intracellular Ca2+ | Not known | (Nath et al., 1995; Self et al., 2004) | |
11 | HCV, DEVN, ZIKV | Not Known | TRPV4 | Rise in cytosolic Ca2+ | Viral replication and exit | Doñate-Macián et al. (2018) | |
12 | HBV | HBx | PMCA | Elevation of the cytosolic Ca2+ | Enhances HBV DNA replication and HBV core assembly | Zhou et al. (2013) | |
13 | RV | Not Known | NCX | Rise in cytosolic Ca2+ | RV replication | Díaz et al. (2012) | |
ER | 1 | RV | NSP4 | Acts as ER Viroporin | Depletes ER Ca2+ and increase in cytosolic Ca2+ | Viral replication and assembly | (Díaz et al., 2008; Hyser et al., 2013; Pham et al., 2017) |
2 | HCMV | US21 | Acts as ER Viroporin | Depletes ER Ca2+ stores | Decreases cell susceptibility to apoptosis | Luganini et al. (2018) | |
3 | HCMV | UL37 | IP3R | Mobilizes Ca2+ from ER to cytosol | Enhanced ATP production to meet viral energy demands | Sharon-Friling et al. (2006) | |
4 | HCMV | US28 | Triggers PLC-β signaling | Release of intracellular Ca2+ | May have role in latent infection | Miller et al. (2012) | |
5 | HCMV | vCXCL1 | Agonist for human chemokines CXCR1 and CXCR2 | Intracellular Ca2+ release | Viral dissemination through the host | (Penfold et al., 1999; Wang et al., 2003) | |
6 | EBV | LMP-1 | SERCA3 | Increase in resting cytosolic Ca2+ levels | Development of latent, persistent infection and cell immortalization | Dellis et al. (2009) | |
7 | HIV | Gag | IP3R | Ca2+ release from ER | Viral budding, formation of VLPs | (Ehrlich et al, 2011, 2014; Ehrlich and Carter, 2012) | |
8 | HIV | Nef | IP3R | Ca2+ release from ER | AIDS pathogenesis | (Ehrlich et al., 2010; Manninen and Saksela, 2002) | |
9 | HBV | HBx | IP3R | Increase in mitochondrial Ca2+ uptake | Aid in viral replication | Yang and Bouchard (2012) | |
10 | HSV | Not defined | IP3R | Increases cytosolic Ca2+ | Viral penetration, delivery of viral capsids to host cell's nucleus. | (Cheshenko et al, 2003, 2007) | |
Mitochondria | 1 | HBV | HBx | mPTP | Releases Ca2+ from mitochondria | Regulates HBV replication | Bouchard et al. (2001) |
2 | HCV | NS5A | MCU | Increased mitochondrial Ca2+ influx and nuclear translocation of transcription factors | Helps in viral pathogenesis | Gong et al. (2001) | |
3 | HCV | HCV polyprotein | MCU | Increase in mitochondrial Ca2+ influx | May induce apoptosis | Piccoli et al. (2007) | |
4 | HCV | Core protein | MCU | Increase in mitochondrial Ca2+ uptake | Increases ROS production and alters apoptosis | Li et al. (2007) | |
5 | HEV | Orf3 | VDAC1 | Upregulation of VDAC | Enhances viral replication | Moin et al. (2007) | |
6 | HIV-1 | Tat | MCU | Increase in mitochondrial Ca2+ uptake | Host cell apoptosis | (Kruman II et al., 1998) | |
7 | HIV-1 | Tat | VDAC | Rise in mitochondrial Ca2+ | Host cell apoptosis | Lecoeur et al. (2012) | |
8 | PV | Not known | VDAC and MCU | Increase mitochondrial Ca2+ levels | Apoptosis induction | Brisac et al. (2010) | |
Lysosomes | 1 | EBOV and Marburgvirus | Not known | TPC2 | Ca2+ release from lysosomes | EBOV entry and infection, Marburgvirus infection |
(Penny et al., 2019; Sakurai et al., 2015; Simmons et al., 2016) |
2 | Polyomavirus | Not known | TPC1/2 | Ca2+ release from lysosomes | Viral entry | Dobson et al. (2020) | |
3 | MERS-CoV | Furin | TPCs | Ca2+ release from lysosomes | Viral entry | Gunaratne et al. (2018) | |
4 | SARS-CoV-2 | Not known | TPC2 | Ca2+ release from lysosomes | Viral entry | Ou et al. (2020) | |
5 | HIV-1 | Tat | TRPML1 | Ca2+ release from lysosomes | HIV-1 replication and latent infections | Khan et al. (2019) | |
Golgi | 1 | DENV, ZIKV, CHIKV, RSV and Measles virus | Not known | SPCA1 | – | Viral maturation and exit | Hoffmann et al. (2017) |
2 | AAV | Not known | SPCA1 | Perturbs cytosolic Ca2+ | AAV transduction | (Madigan et al., 2020; Pillay et al., 2016) | |